The prevalence of symptoms of depressive, anxiety, and D&A in
the cohort were 43.6%, 43.3%, and 31.9%, respectively. The prevalence
of depressive, anxiety, and comorbid D&A symptoms, per MVPA and
SB group can be seen in figure 1.